04 Oct 2024
// PRESS RELEASE
17 Jun 2024
// PRESS RELEASE
13 Jun 2024
// PRESS RELEASE
Latest Content by PharmaCompass
01 6MORPHINE SULFATE
01 6CAPSULE (EXTENDED RELEASE)
01 1100MG
02 110MG
03 115MG
04 1200MG
05 130MG
06 160MG
01 6M-ESLON
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 15MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2177749
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 200MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2177757
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 30MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019949
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 100MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019965
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 60MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019957
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 10MG
Packaging : 20/50
Brand Name : M-ESLON
Approval Date :
Application Number : 2019930
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
LOOKING FOR A SUPPLIER?